SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Juan J. Díez, Enrique Grande, Pedro Iglesias, Ablación posquirúrgica con radioyodo en pacientes con carcinoma diferenciado de tiroides de bajo riesgo, Medicina Clínica, 2015, 144, 1, 35

    CrossRef

  2. 2
    Giovanni Tallini, Dario de Biase, Cosimo Durante, Giorgia Acquaviva, Michele Bisceglia, Rocco Bruno, Maria Letizia Bacchi Reggiani, Gian Piero Casadei, Giuseppe Costante, Nadia Cremonini, Livia Lamartina, Domenico Meringolo, Francesco Nardi, Annalisa Pession, Kerry J Rhoden, Giuseppe Ronga, Massimo Torlontano, Antonella Verrienti, Michela Visani, Sebastiano Filetti, BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study, Modern Pathology, 2015,

    CrossRef

  3. 3
    Juan José Díez, Amelia Oleaga, Cristina Álvarez-Escolá, Tomás Martín, Juan Carlos Galofré, Guía clínica para el manejo de pacientes con carcinoma diferenciado de tiroides de bajo riesgo, Endocrinología y Nutrición, 2015, 62, 6, e57

    CrossRef

  4. 4
    Linwah Yip, Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy, Journal of Surgical Oncology, 2015, 111, 1
  5. 5
    Fábio Muradás Girardi, Marinez Bizarro Barra, Cláudio Galleano Zettler, Predictive Factors for Lymph Node Metastasis in Solitary Papillary Thyroid Carcinomas: A Retrospective Study, Pathology & Oncology Research, 2015, 21, 1, 59

    CrossRef

  6. 6
    Joel A. Smith, Neil Sharma, Paul Nankivell, John C. Watkinson, The presentation, natural history and outcome of T1 a/b thyroid cancer with regard to new grading systems, European Archives of Oto-Rhino-Laryngology, 2015, 272, 2, 439

    CrossRef

  7. 7
    Eugenia Mato, Sílvia Barceló-Batllori, Irene Orera, Laia Selva, Martina Corra, Cintia González, Olga Bell, Enrique Lerma, Antonio Moral, José Ignacio Pérez, Alberto de Leiva, The proteomic 2D-DIGE approach reveals the protein voltage-dependent anion channel 2 as a potential therapeutic target in epithelial thyroid tumours, Molecular and Cellular Endocrinology, 2015, 404, 37

    CrossRef

  8. 8
    Francisco Igor B. Macedo, Vijay K. Mittal, Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis, Surgical Oncology, 2015, 24, 2, 117

    CrossRef

  9. 9
    Linwah Yip, Robert L. Ferris, Clinical Application of Molecular Testing of Fine-needle Aspiration Specimens in Thyroid Nodules, Otolaryngologic Clinics of North America, 2014, 47, 4, 557

    CrossRef

  10. 10
    Frederick L. Kiechle, Rodney C. Arcenas, Linda C. Rogers, Establishing benchmarks and metrics for disruptive technologies, inappropriate and obsolete tests in the clinical laboratory, Clinica Chimica Acta, 2014, 427, 131

    CrossRef

  11. 11
    Ronald Ghossein, Ian Ganly, Agnese Biagini, Eyal Robenshtok, Michael Rivera, R. Michael Tuttle, Prognostic Factors in Papillary Microcarcinoma with Emphasis on Histologic Subtyping: A Clinicopathologic Study of 148 Cases, Thyroid, 2014, 24, 2, 245

    CrossRef

  12. 12
    Ozan B. Ozgursoy, David W. Eisele, Ralph P. Tufano, The Prognostic Implications from Molecular Testing of Thyroid Cancer, Otolaryngologic Clinics of North America, 2014, 47, 4, 595

    CrossRef

  13. 13
    Min Liu, Maomei Ruan, Libo Chen, Update on the molecular diagnosis and targeted therapy of thyroid cancer, Medical Oncology, 2014, 31, 6

    CrossRef

  14. 14
    Renu K Virk, Alison L Van Dyke, Alexander Finkelstein, Avinash Prasad, Joanna Gibson, Pei Hui, Constantine G Theoharis, Tobias Carling, Sanziana A Roman, Julie A Sosa, Robert Udelsman, Manju L Prasad, BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype–phenotype correlation, Modern Pathology, 2013, 26, 1, 62

    CrossRef

  15. 15
    Robert L. Witt, Robert L. Ferris, Edmund A. Pribitkin, Steven I. Sherman, David L. Steward, Yuri E. Nikiforov, Diagnosis and management of differentiated thyroid cancer using molecular biology, The Laryngoscope, 2013, 123, 4
  16. 16
    Leslie S. Wu, Stacey A. Milan, Management of microcarcinomas (papillary and medullary) of the thyroid, Current Opinion in Oncology, 2013, 25, 1, 27

    CrossRef

  17. You have free access to this content17
    David F. Schneider, Herbert Chen, New developments in the diagnosis and treatment of thyroid cancer, CA: A Cancer Journal for Clinicians, 2013, 63, 6
  18. 18
    Simonetta Piana, Moira Ragazzi, Giovanni Tallini, Dario de Biase, Alessia Ciarrocchi, Andrea Frasoldati, Juan Rosai, Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases, Human Pathology, 2013, 44, 4, 556

    CrossRef

  19. 19
    Leonard Wartofsky, Should patients with papillary microcarcinoma undergo radioiodine ablation?, Endocrine, 2013, 44, 2, 278

    CrossRef

  20. 20
    Charalampos Seretis, Stavros Gourgiotis, George Gemenetzis, Fotios Seretis, Emmanuel Lagoudianakis, George Dimitrakopoulos, The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study, The American Journal of Surgery, 2013, 205, 6, 691

    CrossRef

  21. 21
    Scott K. Sherman, James R. Howe, Translational Research in Endocrine Surgery, Surgical Oncology Clinics of North America, 2013, 22, 4, 857

    CrossRef

  22. 22
    Vikas Mehta, Yuri E. Nikiforov, Robert L. Ferris, Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgery, Head & Neck, 2013, 35, 10
  23. 23
    Zvonimir L Milas, Jennifer Brainard, Mira Milas, Clinical Management of Thyroid Cancer, 2013,

    CrossRef

  24. 24
    Jason D. Prescott, Peter M. Sadow, Richard A. Hodin, Long Phi Le, Randall D. Gaz, Gregory W. Randolph, Antonia E. Stephen, Sareh Parangi, Gilbert H. Daniels, Carrie C. Lubitz, BRAFV600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence, Surgery, 2012, 152, 6, 984

    CrossRef